Keymed Biosciences, Inc.'s total assets for Q2 2025 were ¥4.63B, an increase of 22.95% from the previous quarter. HK:2162 total liabilities were ¥1.44B for the fiscal quarter, a 11.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.